Literature DB >> 3801784

The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues.

P Leff, G R Martin, J M Morse.   

Abstract

In a previous study, we attempted to verify the classification of 5-hydroxytryptamine2 (5-HT2) receptors in three vascular tissues, by use of the conventional antagonists, ketanserin, spiperone, methysergide and trazodone. However, it was not possible to conclude homogeneity of the receptor type in the three tissues due to the inconsistent behaviour of these antagonists, in particular, their apparently variable affinities between the tissues. These results led to the reliability of the conventional antagonists being questioned as receptor probes. In the present study, a set of tryptamine analogues were investigated in two of the tissues, the rabbit aorta and the rat jugular vein. Unlike the conventional antagonists, these compounds bear a close chemical relation to the natural agonist, 5-HT. In both tissues, alpha, alpha-dimethyltryptamine demonstrated apparently simple competitive antagonism of 5-HT-induced constrictions. Its affinity was estimated to be the same in each case. The affinities and relative efficacies of 5-HT, 5-cyanotryptamine, N,N-dimethyltryptamine and N-benzyl-5-methoxytryptamine were also found to be indistinguishable between the two tissues. Unlike the conventional 5-HT2 receptor antagonists, these tryptamine analogues failed to distinguish between the 5-HT receptors in the rabbit aorta and rat jugular vein implying that they truly belong to the same class. In view of this result, it is suggested that simple tryptamine analogues are more reliable probes for 5-HT receptor classification than ligands which bear little or no chemical relation to the natural agonist.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3801784      PMCID: PMC1917160          DOI: 10.1111/j.1476-5381.1986.tb11149.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  Calcitonin: antagonism at intestinal muscarinic receptors.

Authors:  C F Dreyfus; M D Gershon; A Haymovits; E Nunez
Journal:  Br J Pharmacol       Date:  1976-05       Impact factor: 8.739

2.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

3.  Ketanserin--a novel antihypertensive drug?

Authors:  P P Humphrey; W Feniuk; A D Watts
Journal:  J Pharm Pharmacol       Date:  1982-08       Impact factor: 3.765

4.  Further evidence that vascular serotonin receptors are of the 5HT2 type.

Authors:  M L Cohen; N Mason; K S Wiley; R W Fuller
Journal:  Biochem Pharmacol       Date:  1983-02-01       Impact factor: 5.858

5.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

Authors:  J E Leysen; C J Niemegeers; J M Van Nueten; P M Laduron
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

6.  Developments of computer-based estimation of pA2 values and associated analysis.

Authors:  M Stone; J A Angus
Journal:  J Pharmacol Exp Ther       Date:  1978-12       Impact factor: 4.030

7.  Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta.

Authors:  J S Stollak; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

8.  Noradrenergic component in the vasoconstriction induced by 5-hydroxytryptamine in goat cerebral arteries.

Authors:  J Marin; M Salaices; B Gómez; S Lluch
Journal:  J Pharm Pharmacol       Date:  1981-11       Impact factor: 3.765

9.  An action of 5-hydroxytryptamine on adrenaline receptors.

Authors:  I R INNES
Journal:  Br J Pharmacol Chemother       Date:  1962-12

10.  Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5 HT2 receptors.

Authors:  A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

View more
  6 in total

1.  Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.

Authors:  S J MacLennan; G R Martin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Classification of platelet and vascular prostaglandin D2 (DP) receptors: estimation of affinities and relative efficacies for a series of novel bicyclic ligands. With an appendix on goodness-of-fit analyses.

Authors:  P Leff; H Giles
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines.

Authors:  G R Martin; P Leff; D Cambridge; V J Barrett
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

4.  Differential classification of vascular smooth muscle and endothelial cell 5-HT receptors by use of tryptamine analogues.

Authors:  P Leff; G R Martin; J M Morse
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

5.  Differences in agonist dissociation constant estimates for 5-HT at 5-HT2-receptors: a problem of acute desensitization?

Authors:  P Leff; G R Martin
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

6.  N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues.

Authors:  David E Nichols; M Flori Sassano; Adam L Halberstadt; Landon M Klein; Simon D Brandt; Simon P Elliott; Wolfgang J Fiedler
Journal:  ACS Chem Neurosci       Date:  2015-01-21       Impact factor: 4.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.